HIV surveillance must keep pace with advances in antiretroviral therapy

被引：4

作者：

Goldberg, D ^{[1
]}

Nandwani, R ^{[1
]}

机构：

[1] Scottish Ctr Infect & Environm Hlth, Glasgow, Lanark, Scotland

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 1998年 / 9卷 / 10期

关键词：

HIV; AIDS; surveillance; prediction; antiretroviral; combination therapy; treatment; HAART; CD4; count; sexually transmitted diseases; Scotland;

D O I：

10.1258/0956462981921035

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：559 / 560

页数：2

共 17 条

[1] The recent impact of antiretroviral combination therapy on CD4 counts, AIDS and death in HIV-infected persons: routine HIV surveillance in Scotland [J].

Allardice, GM ;

McMenamin, JJ ;

Parpia, T ;

Gibbs, J ;

McSharry, C ;

Whitelaw, J .

INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (10) :561-566

[2]

[Anonymous], 1996, Lancet, V348, P283

[3] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969

[4] Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154

[5]

CARR A, 1998, 5 C RETR OPP INF 1 5

[6] Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].

Egger, M ;

Hirschel, B ;

Francioli, P ;

Sudre, P ;

Wirz, M ;

Flepp, M ;

Rickenbach, M ;

Malinverni, R ;

Vernazza, P ;

Battegay, M ;

Bernasconi, E ;

Burgisser, P ;

Erb, P ;

Fierz, W ;

Grob, P ;

Gruninger, U ;

Jeannerod, L ;

Ledergerber, B ;

Luthy, R ;

Matter, L ;

Opravil, M ;

Paccaud, F ;

Perrin, L ;

Pichler, W ;

Piffaretti, GC ;

Rutschmann, O ;

Zanetti, G .

BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199

[7] British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals [J].

Gazzard, BG ;

Moyle, GJ ;

Weber, J ;

Johnson, M ;

Bingham, JS ;

Brettle, R ;

Churchill, D ;

Fisher, M ;

Griffin, G ;

Jefferies, D ;

King, E ;

Gormer, R ;

Lee, C ;

Pozniak, A ;

Smith, JR ;

TudorWilliams, G ;

Williams, I .

LANCET, 1997, 349 (9058) :1086-1092

[8] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

[9] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].

Hammer, SM ;

Squires, KE ;

Hughes, MD ;

Grimes, JM ;

Demeter, LM ;

Currier, JS ;

Eron, JJ ;

Feinberg, JE ;

Balfour, HH ;

Dayton, LR ;

Chodakewitz, JA ;

Fischl, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733

[10] CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART) [J].

Kaufmann, D ;

Pantaleo, G ;

Sudre, P ;

Telenti, A .

LANCET, 1998, 351 (9104) :723-724

← 1 2 →